AAPL347.10+3.19 (+0.93%) ▲|ABBV286.39-0.35 (-0.12%) ▼|ABT103.10-1.78 (-1.70%) ▼|ACN235.16-12.07 (-4.88%) ▼|ADBE248.36-10.26 (-3.97%) ▼|AMAT395.93+8.34 (+2.15%) ▲|AMD560.26+28.98 (+5.45%) ▲|AMGN447.95+3.32 (+0.75%) ▲|AMT183.83-4.45 (-2.36%) ▼|AMZN253.10+4.01 (+1.61%) ▲|AVGO342.33+13.16 (+4.00%) ▲|AXP312.91-2.14 (-0.68%) ▼|BA168.18-20.13 (-10.69%) ▼|BAC50.68+0.16 (+0.32%) ▲|BKNG150.14-3.00 (-1.96%) ▼|BLK1,136.05+8.39 (+0.74%) ▲|BMY61.55-0.06 (-0.10%) ▼|BNY147.58+0.40 (+0.27%) ▲|BRK-B542.99-5.57 (-1.02%) ▼|C122.69+1.65 (+1.36%) ▲|CAT713.31+21.18 (+3.06%) ▲|CL92.17-0.93 (-1.00%) ▼|CMCSA21.84-0.21 (-0.95%) ▼|COF203.44+1.09 (+0.54%) ▲|COP147.96-3.41 (-2.25%) ▼|COST992.13-13.03 (-1.30%) ▼|CRM240.89-6.72 (-2.71%) ▼|CSCO111.38+1.14 (+1.03%) ▲|CVS91.13-1.40 (-1.51%) ▼|CVX228.23-3.78 (-1.63%) ▼|DE639.58-1.67 (-0.26%) ▼|DHR232.00-0.97 (-0.42%) ▼|DIS110.23-0.17 (-0.15%) ▼|DUK124.80+0.36 (+0.29%) ▲|EMR166.27+4.57 (+2.83%) ▲|FDX307.10+6.52 (+2.17%) ▲|GD354.89-2.15 (-0.60%) ▼|GE297.66+9.23 (+3.20%) ▲|GEV895.08+40.46 (+4.73%) ▲|GILD159.08+0.39 (+0.25%) ▲|GM80.54+4.23 (+5.54%) ▲|GOOG316.83+2.64 (+0.84%) ▲|GOOGL320.58+3.78 (+1.19%) ▲|GS911.77+18.49 (+2.07%) ▲|HD318.50-0.88 (-0.28%) ▼|HON218.81-0.47 (-0.21%) ▼|IBM250.25-3.19 (-1.26%) ▼|INTC93.74+3.27 (+3.61%) ▲|INTU328.45-11.44 (-3.37%) ▼|ISRG445.88-5.75 (-1.27%) ▼|JNJ268.73+2.43 (+0.91%) ▲|JPM335.79+1.75 (+0.52%) ▲|KO91.18-1.52 (-1.64%) ▼|LIN508.65+1.09 (+0.21%) ▲|LLY1,281.91+2.77 (+0.22%) ▲|LMT622.99-12.21 (-1.92%) ▼|LOW198.18-0.04 (-0.02%) ▼|LRCX240.85+3.35 (+1.41%) ▲|MA609.85-3.65 (-0.59%) ▼|MCD249.47-1.36 (-0.54%) ▼|MDLZ62.35-0.62 (-0.98%) ▼|MDT93.95-0.84 (-0.89%) ▼|META620.19-10.37 (-1.64%) ▼|MMM171.58-1.21 (-0.70%) ▼|MO73.49-0.13 (-0.18%) ▼|MRK141.82+1.21 (+0.86%) ▲|MS186.91+3.42 (+1.86%) ▲|MSFT531.33-1.27 (-0.24%) ▼|MU928.76+25.06 (+2.77%) ▲|NEE82.42+0.38 (+0.46%) ▲|NFLX62.52-1.38 (-2.16%) ▼|NKE37.56-0.35 (-0.92%) ▼|NOW154.78-3.40 (-2.15%) ▼|NVDA217.94+1.94 (+0.90%) ▲|ORCL130.53+4.47 (+3.55%) ▲|PEP133.50-1.96 (-1.45%) ▼|PFE29.80+0.01 (+0.03%) ▲|PG159.23-0.69 (-0.43%) ▼|PLTR198.73-0.11 (-0.06%) ▼|PM202.62+0.75 (+0.37%) ▲|QCOM184.17+4.57 (+2.54%) ▲|RTX194.60-2.88 (-1.46%) ▼|SBUX103.04+0.35 (+0.34%) ▲|SCHW89.30-0.43 (-0.48%) ▼|SO92.65+0.08 (+0.09%) ▲|SPG212.28-0.41 (-0.19%) ▼|T20.94+0.09 (+0.43%) ▲|TMO693.02+8.13 (+1.19%) ▲|TMUS146.83-0.10 (-0.07%) ▼|TSLA407.46+15.84 (+4.04%) ▲|TXN308.91+10.79 (+3.62%) ▲|UBER65.78-0.35 (-0.53%) ▼|UNH410.39-0.31 (-0.08%) ▼|UNP299.88+2.91 (+0.98%) ▲|UPS106.09+5.77 (+5.75%) ▲|USB59.74+0.04 (+0.07%) ▲|V401.86-2.30 (-0.57%) ▼|VZ43.93+0.83 (+1.93%) ▲|WFC82.66+0.01 (+0.01%) ▲|WMT119.32-0.97 (-0.81%) ▼|XOM179.91-4.63 (-2.51%) ▼|AAPL347.10+3.19 (+0.93%) ▲|ABBV286.39-0.35 (-0.12%) ▼|ABT103.10-1.78 (-1.70%) ▼|ACN235.16-12.07 (-4.88%) ▼|ADBE248.36-10.26 (-3.97%) ▼|AMAT395.93+8.34 (+2.15%) ▲|AMD560.26+28.98 (+5.45%) ▲|AMGN447.95+3.32 (+0.75%) ▲|AMT183.83-4.45 (-2.36%) ▼|AMZN253.10+4.01 (+1.61%) ▲|AVGO342.33+13.16 (+4.00%) ▲|AXP312.91-2.14 (-0.68%) ▼|BA168.18-20.13 (-10.69%) ▼|BAC50.68+0.16 (+0.32%) ▲|BKNG150.14-3.00 (-1.96%) ▼|BLK1,136.05+8.39 (+0.74%) ▲|BMY61.55-0.06 (-0.10%) ▼|BNY147.58+0.40 (+0.27%) ▲|BRK-B542.99-5.57 (-1.02%) ▼|C122.69+1.65 (+1.36%) ▲|CAT713.31+21.18 (+3.06%) ▲|CL92.17-0.93 (-1.00%) ▼|CMCSA21.84-0.21 (-0.95%) ▼|COF203.44+1.09 (+0.54%) ▲|COP147.96-3.41 (-2.25%) ▼|COST992.13-13.03 (-1.30%) ▼|CRM240.89-6.72 (-2.71%) ▼|CSCO111.38+1.14 (+1.03%) ▲|CVS91.13-1.40 (-1.51%) ▼|CVX228.23-3.78 (-1.63%) ▼|DE639.58-1.67 (-0.26%) ▼|DHR232.00-0.97 (-0.42%) ▼|DIS110.23-0.17 (-0.15%) ▼|DUK124.80+0.36 (+0.29%) ▲|EMR166.27+4.57 (+2.83%) ▲|FDX307.10+6.52 (+2.17%) ▲|GD354.89-2.15 (-0.60%) ▼|GE297.66+9.23 (+3.20%) ▲|GEV895.08+40.46 (+4.73%) ▲|GILD159.08+0.39 (+0.25%) ▲|GM80.54+4.23 (+5.54%) ▲|GOOG316.83+2.64 (+0.84%) ▲|GOOGL320.58+3.78 (+1.19%) ▲|GS911.77+18.49 (+2.07%) ▲|HD318.50-0.88 (-0.28%) ▼|HON218.81-0.47 (-0.21%) ▼|IBM250.25-3.19 (-1.26%) ▼|INTC93.74+3.27 (+3.61%) ▲|INTU328.45-11.44 (-3.37%) ▼|ISRG445.88-5.75 (-1.27%) ▼|JNJ268.73+2.43 (+0.91%) ▲|JPM335.79+1.75 (+0.52%) ▲|KO91.18-1.52 (-1.64%) ▼|LIN508.65+1.09 (+0.21%) ▲|LLY1,281.91+2.77 (+0.22%) ▲|LMT622.99-12.21 (-1.92%) ▼|LOW198.18-0.04 (-0.02%) ▼|LRCX240.85+3.35 (+1.41%) ▲|MA609.85-3.65 (-0.59%) ▼|MCD249.47-1.36 (-0.54%) ▼|MDLZ62.35-0.62 (-0.98%) ▼|MDT93.95-0.84 (-0.89%) ▼|META620.19-10.37 (-1.64%) ▼|MMM171.58-1.21 (-0.70%) ▼|MO73.49-0.13 (-0.18%) ▼|MRK141.82+1.21 (+0.86%) ▲|MS186.91+3.42 (+1.86%) ▲|MSFT531.33-1.27 (-0.24%) ▼|MU928.76+25.06 (+2.77%) ▲|NEE82.42+0.38 (+0.46%) ▲|NFLX62.52-1.38 (-2.16%) ▼|NKE37.56-0.35 (-0.92%) ▼|NOW154.78-3.40 (-2.15%) ▼|NVDA217.94+1.94 (+0.90%) ▲|ORCL130.53+4.47 (+3.55%) ▲|PEP133.50-1.96 (-1.45%) ▼|PFE29.80+0.01 (+0.03%) ▲|PG159.23-0.69 (-0.43%) ▼|PLTR198.73-0.11 (-0.06%) ▼|PM202.62+0.75 (+0.37%) ▲|QCOM184.17+4.57 (+2.54%) ▲|RTX194.60-2.88 (-1.46%) ▼|SBUX103.04+0.35 (+0.34%) ▲|SCHW89.30-0.43 (-0.48%) ▼|SO92.65+0.08 (+0.09%) ▲|SPG212.28-0.41 (-0.19%) ▼|T20.94+0.09 (+0.43%) ▲|TMO693.02+8.13 (+1.19%) ▲|TMUS146.83-0.10 (-0.07%) ▼|TSLA407.46+15.84 (+4.04%) ▲|TXN308.91+10.79 (+3.62%) ▲|UBER65.78-0.35 (-0.53%) ▼|UNH410.39-0.31 (-0.08%) ▼|UNP299.88+2.91 (+0.98%) ▲|UPS106.09+5.77 (+5.75%) ▲|USB59.74+0.04 (+0.07%) ▲|V401.86-2.30 (-0.57%) ▼|VZ43.93+0.83 (+1.93%) ▲|WFC82.66+0.01 (+0.01%) ▲|WMT119.32-0.97 (-0.81%) ▼|XOM179.91-4.63 (-2.51%) ▼|
11.8 C
New York
Wednesday, October 28, 2026

Tag: networks

Actelis Networks Accelerates US Federal Government and Military Expansion Efforts, Hires Industry Veteran Sales Director as Company accelerates efforts in Major Military Branches

Strategic federal initiative includes appointment of Jason Chasse, a US Federal and Military sales veteran with over 30 years of experience, as Director of Federal Sales.
Strategic federal initiative includes appointment of Jason Chasse, a US Federal and Military sales veteran with over 30 years of experience, as Director of Federal Sales.

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate...

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, a modifier gene therapy candidate being developed for all Stargardt disease (ABCA4-associated retinopathies). The FDA previously granted Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation for OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa 19, and cone-rod dystrophy 3.

8th Asia Dengue Summit Renews Call to Achieve Zero Dengue Deaths, with a Record 14 million Global Cases Reported in 2024

Health leaders, researchers, and advocates unite to advance efforts against dengue through innovation, prevention, and cross-sector collaboration. MANILA, Philippines, June 16, 2025 /PRNewswire/ -- As...

STL expands Data Centre portfolio to meet emerging requirements for AI data centres

- High-performance, comprehensive cabling and connectivity solutions and engineering services - Fully compliant solutions, meeting international standards MUMBAI, India, June 16, 2025 /PRNewswire/ -- STL (NSE:...

Global Times: Practitioners’ Insights: Urban-rural bus Route 101 – a vivid practice of ‘following a good blueprint through to the end’

BEIJING, June 15, 2025 /PRNewswire/ -- In the early morning, the lights of the Daxin Road bus hub in downtown Jiaxing cut through the mist....

Mastercard onboards customers up to four times faster with Cloud Edge

Backed by leading cloud providers like AWS, Cloud Edge gives customers greater flexibility and choice SINGAPORE, June 16, 2025 /PRNewswire/ -- Mastercard today announced that...

Eve Air Mobility and Revo Accelerate Urban Air Mobility with $250M Contract

A fleet of up to 50 aircraft and aftermarket services is poised to revolutionize urban transport across Revo's key markets. PARIS, June 15, 2025 /PRNewswire/ -- Eve Air Mobility ("Eve") (NYSE: EVEX) (NYSE: EVEXW) has signed its first binding framework agreement with...

Meta Develops Superintelligence Lab: Assessing AI’s Impact on Quantitative Models

**Title: Meta's Strategic Investment in AI: A Quantitative Perspective** **Introduction** Meta Platforms Inc. has announced a strategic $14.3 billion investment in a new artificial intelligence (AI)...

The Power Behind BACXN: A Global Elite Team Driving Platform Innovation and Breakthroughs

DENVER, June 14, 2025 (GLOBE NEWSWIRE) -- BACXN has recently completed the global assembly and strategic restructuring of its core team, officially launching a comprehensive upgrade covering technology development, security and risk management, and market expansion. This milestone marks the platform transition from a regional startup to global collaborative operations. Supporting this transformation is a core team spanning blockchain, fintech, cybersecurity, and global markets. They not only bring professional expertise but also drive the continuous evolution of BACXN with a systematic vision.

$1 Deposit Casinos Canada: RoboCat Casino Launches 1 Dollar Deposits

RoboCat now accepts deposits from just $1 and offers exclusive bonuses and rewards on small deposits, making online casino gaming more accessible for everyone
RoboCat now accepts deposits from just $1 and offers exclusive bonuses and rewards on small deposits, making online casino gaming more accessible for everyone

Rivalry Provides Update on Management Cease Trade Order

TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), is providing this bi-weekly update on the status of a management cease trade order granted on May 1, 2025 (the "MCTO") by its principal regulator, the Ontario Securities Commission (the "OSC"), under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On May 2, 2025, the Company announced that there would be a delay in the filing of its annual financial statements, management’s discussion and analysis and related CEO and CFO certificates for the fiscal year ended December 31, 2024 (collectively, the “Annual Filings”), as required under applicable Canadian securities laws (the "Default Announcement"). As stated in the Default Announcement, the Company expects to complete the Annual Filings by June 30, 2025.

HYL Soars on Launch: PrexaSwap Partners with HyperLink to Ignite a New Order in Web3 Connectivity

Los Angeles, CA, June 13, 2025 (GLOBE NEWSWIRE) -- Today marks a significant breakthrough in the global Web3 infrastructure sector. HyperLink (token symbol: HYL), hailed as a "revolutionary protocol innovator," officially launched trading on the globally compliant digital asset exchange, PrexaSwap. Following its launch, HYL demonstrated strong market performance, with prices surging and liquidity quickly consolidating, becoming one of the most talked-about protocol assets across the network in a short time.



HyperLink is not a traditional public chain or Layer 2 scaling solution; rather, it is a foundational technology platform positioned as a "Link Layer" protocol. It aims to create a universal protocol framework that enables the "structured linking, intelligent combination, and semantic execution" of identities, assets, content, and contracts within the Web3 ecosystem.



The project's core technological architecture consists of four major modules:

- LinkCore: A native linking engine that enables verifiable cross-chain linking and structural calls.

- LinkID: A unified multi-chain identity binding system that supports the integration of Web2 and Web3 social platforms.

- LinkMesh: A distributed semantic graph network used to index on-chain content and interaction logic.

- LinkAI: An AI-driven intelligent behavior engine that can automatically identify user intent and generate optimal linking paths.



This architecture effectively addresses current issues in the Web3 ecosystem, such as "contract islands," "identity fragmentation," and "data interoperability." It provides revolutionary foundational support for scenarios like DeFi strategy combinations, unified decentralized identities (DID), smart wallet navigation, and real-world asset (RWA) execution layer integration.



PrexaSwap, the exchange where HyperLink launched, is a robust platform that provides strong support for global Web3 protocol projects. As a globally compliant exchange registered in the U.S. and holding an MSB (Money Services Business) financial license, PrexaSwap leads the industry in liquidity building, security auditing, AI risk control engines, and intelligent matching. The platform has established multi-layer risk control measures and deep audit collaborations with institutions such as Chainalysis, CertiK, and SlowMist, successfully supporting multiple infrastructure projects in their launch phases, thereby gaining the trust of numerous institutions and developers.



The strategic collaboration between HyperLink and PrexaSwap not only initiates trading and circulation but also aims for deep protocol integration regarding account systems, fee models, and compliance interfaces. In the future, users will experience practical features like one-click login via LinkID, semantic trading entry based on LinkAI, and structured asset invocation modules on PrexaSwap, evolving the exchange from a trading platform to a "protocol-based trading entry."



Notably, Alex Xu, a core member, publicly stated: "The emergence of HyperLink signifies the official entry of Web3 into the semantic linking era. It is not just about multi-chain interoperability; it is about defining how collaboration occurs between multiple chains." Additionally, a director of investments, "Projects like HyperLink that do not attempt to replace old protocols but enable them to collaborate more efficiently will become the core narrative of the next cycle."



On the community front, discussions about HyperLink have continued to escalate post-launch. Numerous KOLs on platforms like Twitter, Telegram, and Reddit are actively interpreting project mechanisms and analyzing its technical breakthroughs and ecological value. Many developers have started submitting aggregated wallets, contract orchestration tools, and linking content aggregation applications built on the HyperLink SDK, with ecological vitality rapidly spreading.



The PrexaSwap platform has also announced plans to launch a global node recruitment program, developer incentive program, and "protocol as a service" API promotion plan in conjunction with the HYL launch, further deepening HyperLink's global ecological deployment.

Current market consensus is becoming increasingly clear: HYL is not just an asset; it is a structural entry point, reshaping the entire Web3 linking order. The arrival of HyperLink is pushing Web3 from "bridges between chains" to "networks between structures and logic," an evolution that will determine the direction of the next trillion-dollar protocol platform.

Media Contact

Contact: Mary M. Ivory
Company Name: Hyperlink(HYL)
Website: https://hyperlinkcoin.com/
Email: Mary (at) hyperlinkcoin.com

Contact: Lisa S. Roth
Company Name: Prexaswap
Website: https://trade.prexaswapx.net
Email: Lisa.s (at) prexaswapx.net

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

Trusted Crypto Casinos Are Taking Over Online Gambling in 2025: Exclusive Report By Radcred

Radcred’s exclusive 2025 study reveals the safest, fastest-paying crypto casinos reshaping online gambling. See trends, data, and tips.
Radcred’s exclusive 2025 study reveals the safest, fastest-paying crypto casinos reshaping online gambling. See trends, data, and tips. 

Scripps reaches multi-year agreement with the WNBA to continue Friday night games on ION

NEW YORK and CINCINNATI, June 13, 2025 /PRNewswire/ -- The E.W. Scripps Company (NASDAQ: SSP) today announced a new, multi-year agreement with the Women's...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNetworks